46 related articles for article (PubMed ID: 9787156)
1. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny.
Dworzak MN; Fritsch G; Fröschl G; Printz D; Gadner H
Blood; 1998 Nov; 92(9):3203-9. PubMed ID: 9787156
[TBL] [Abstract][Full Text] [Related]
2. Absence of N addition facilitates B cell development, but impairs immune responses.
Schelonka RL; Ivanov II; Vale AM; Dimmitt RA; Khaled M; Schroeder HW
Immunogenetics; 2011 Sep; 63(9):599-609. PubMed ID: 21660592
[TBL] [Abstract][Full Text] [Related]
3. IL-15 gene mutation as a molecular risk factor in acute lymphoid leukemia.
Mohammed SI; Hassan KM; Azeez DM; Qadir FA; Salihi AB
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):10-17. PubMed ID: 38814240
[TBL] [Abstract][Full Text] [Related]
4. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
[TBL] [Abstract][Full Text] [Related]
5. Testing gene function early in the B cell lineage in mb1-cre mice.
Hobeika E; Thiemann S; Storch B; Jumaa H; Nielsen PJ; Pelanda R; Reth M
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13789-94. PubMed ID: 16940357
[TBL] [Abstract][Full Text] [Related]
6. Identification of B cells through negative gating-An example of the MIFlowCyt standard applied.
Blimkie D; Fortuno ES; Thommai F; Xu L; Fernandes E; Crabtree J; Rein-Weston A; Jansen K; Brinkman RR; Kollmann TR
Cytometry A; 2010 Jun; 77(6):546-51. PubMed ID: 20131398
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine Successfully Treats Intracranial Enterovirus E18 Infection in a Patient with CD79a Deficiency Arising from Segmental Uniparental Disomy of Chromosome 19.
Yu L; Zhang Y; Li W; Mao J; Li Y; Wang H; Li C; Yang L; He W; Jia Y; Tang W; Zhou L; Zhang Z; Jia Y; Tang X; Zhao X; An Y
J Clin Immunol; 2024 May; 44(6):137. PubMed ID: 38805163
[TBL] [Abstract][Full Text] [Related]
8. Human CD79b
Meyer MA; Dinh HQ; Alimadadi A; Araujo DJ; Chatterjee N; Gutierrez NA; Zhu YP; Hunter EL; Liang S; Seumois G; Kiosses WB; Catz SD; Vijayanand P; Ottensmeier C; Hedrick CC
Front Immunol; 2023; 14():1224045. PubMed ID: 38022639
[TBL] [Abstract][Full Text] [Related]
9. MiDReG: a method of mining developmentally regulated genes using Boolean implications.
Sahoo D; Seita J; Bhattacharya D; Inlay MA; Weissman IL; Plevritis SK; Dill DL
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5732-7. PubMed ID: 20231483
[TBL] [Abstract][Full Text] [Related]
10. Decreased IL7Rα and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin.
Rother MB; Jensen K; van der Burg M; van de Bovenkamp FS; Kroek R; van IJcken WF; van der Velden VH; Cupedo T; Olstad OK; van Dongen JJ; van Zelm MC
Sci Rep; 2016 Sep; 6():33924. PubMed ID: 27658954
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.
Elbnnani AS; Elbasir M; Altabal S; Lamami Y; Ebrahim F; Oshah HM; Alagnef R; Elzagheid A; Abulayha AM
Libyan J Med; 2024 Dec; 19(1):2319895. PubMed ID: 38394044
[TBL] [Abstract][Full Text] [Related]
12. Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function.
Leung I; Templeton ML; Lo Y; Rajan A; Stull SM; Garrison SM; Salter AI; Smythe KS; Correnti CE; Srivastava S; Yeung CCS; Riddell SR
Blood Adv; 2023 Jun; 7(12):2718-2730. PubMed ID: 36469024
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression.
Choi JW; Kim YJ; Yun KA; Won CH; Lee MW; Choi JH; Chang SE; Lee WJ
Sci Rep; 2020 Sep; 10(1):14372. PubMed ID: 32873829
[TBL] [Abstract][Full Text] [Related]
14. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.
Hernández-Caselles T; Miguel RC; Ruiz-Alcaraz AJ; García-Peñarrubia P
J Immunol Res; 2019; 2019():6032141. PubMed ID: 31143782
[TBL] [Abstract][Full Text] [Related]
15. Profiling the Atlantic Salmon IgM
Peñaranda MMD; Jensen I; Tollersrud LG; Bruun JA; Jørgensen JB
Front Immunol; 2019; 10():37. PubMed ID: 30761128
[TBL] [Abstract][Full Text] [Related]
16. Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel.
Gupta S; Chatterjee T; Sharma S; Sharma A; Ganguly P; Singh J; Das S
Med J Armed Forces India; 2016 Jul; 72(3):220-30. PubMed ID: 27546960
[TBL] [Abstract][Full Text] [Related]
17. Human B-cell and progenitor stages as determined by probability state modeling of multidimensional cytometry data.
Bagwell CB; Hill BL; Wood BL; Wallace PK; Alrazzak M; Kelliher AS; Preffer FI
Cytometry B Clin Cytom; 2015; 88(4):214-26. PubMed ID: 25850810
[TBL] [Abstract][Full Text] [Related]
18. Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.
Luger D; Yang YA; Raviv A; Weinberg D; Banerjee S; Lee MJ; Trepel J; Yang L; Wakefield LM
PLoS One; 2013; 8(10):e76115. PubMed ID: 24146823
[TBL] [Abstract][Full Text] [Related]
19. Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.
Cowan AJ; Laszlo GS; Estey EH; Walter RB
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1311-34. PubMed ID: 23747885
[TBL] [Abstract][Full Text] [Related]
20. Shortening the immunodeficient period after hematopoietic stem cell transplantation.
André-Schmutz I; Six E; Bonhomme D; Rouiller J; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
Immunol Res; 2009; 44(1-3):54-60. PubMed ID: 19034396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
